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1. INTRODUCTION 
 
1.1. Pharmaceutical Chemistry vs Medicinal Chemistry: 
Pharmaceutical chemistry is a science that makes use of the general laws of 
chemistry to study drugs, i.e., their proportion, chemical nature, composition, influence 
on an organism and studies of the physical and chemical properties of drugs, the method 
of quality control and the condition of their storage. The primary function of the 
pharmaceutical and medicinal chemist is still to design new drugs, with knowledge of 
principles of biochemical action of drug molecules.  
Medicinal chemistry, according to burger, tries to be based on the ever increasing 
hope that biochemical rationales for drug discovery may be found a logical approach to 
study of drugs and their activities is the recognition of the basic principles behind the 
biochemical events leading to drug actions.  
Chemical modifications of drug molecules to locate the number of series having 
optimal effects, and will probably continue to be a factor necessary to drug discovery. To 
establish the structure of the drug molecule the new inventions in physico-chemical 
properties such as X–rays analysis, UV, IR, NMR and Mass are immensely helpful for 
medicinal chemist. In the biochemical view knowledge of drug-receptor interaction, 
pharmacokinetics, advances in enzymology, have immensely helped medicinal chemist in 
hypothesizing the correct mechanism of action of drug molecules. The approach to 
practice the medicinal chemistry has developed from an empirical are involving organic 
synthesis of new compounds, based largely on modification of structures of known 
activity. (Donald J. Abraham., 2002) 
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1.2. Mannich Reaction and Mechanism: 
Mannich bases form a promising group of chemicals which may be a good source 
of potential candidates for future drugs. Our knowledge about their activities at the 
cellular and tissue level is, however, still rather limited. α, β – unsaturated ketones 
released by mannich bases exert their biological activities such as cytotoxicity and anti-
fungal activity by reacting with the vital thiol groups in the living organisms.  
Mannich reaction is one of the most important C-C bond forming reactions in 
organic synthesis for the preparation of secondary and tertiary amine derivatives. These 
amines are further used for the synthesis of many intermediates, biologically active and 
natural products such as alkaloids and polypeptides. The products of Mannich reaction 
are mainly amino carbonyl compounds and its derivatives that are used for the synthesis 
of amino alcohols, peptides and lactams and as precursors to optically active amino acids. 
(Suman Sahoo et al., 2006) 
The Mannich reaction has been reviewed by Blicke, Karbe, Nobles, Reichert, 
Thomson and others and had been mentioned in many books. There are two important 
types of mannich reactions, the C-type (Scheme 1) and the N-type (Scheme 2) reaction. 
 
O
CH3
+ 2 HCHO + NH
R
R
1
C
O
CH2 CH2 N
R
R
1
Acetophenone
 
Scheme 1: C-type Mannich reaction 
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N
H
O
O + (CH3)2NH
HCHO
HCl N
O
O
CH2 N
CH3
CH3
1H-indole-2,3-dione
 
Scheme 2: N-type Mannich reaction 
 
1.3. Synthetic Utilities of Mannich bases: 
 Mannich reactions have been used as a synthetic tool in the preparation of various 
therapeutic agents, fluoxetine, an antidepressant agent (Scheme 3), ethacrynic acid, a 
ceiling loop diuretics (Scheme 4), ranitidine, a H2-receptor antagonist (Scheme 5), 
triprolidine, a H1-receptor antagonist (Scheme 6) and trihexylphenidyl hydrochloride, an 
antispasmodic (Scheme 7). 
 
O
CH3 HCHO/(CH3)2 NH.HCl
O
CH2 CH2 N
CH3
CH3
O
CH2 CH2 N
CH3
CH3
CF3
Acetophenone
Fluoxetine
 
Scheme 3: Synthesis of Fluoxetine 
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CH3 Cl
O
+
Cl Cl
O
COOH
Butanoyl 
chloride
(2,3-dichlorophenoxy)acetic 
acid
AlCl3
CH3
O
Cl Cl
O
COOH
Mannich reaction HCHO, (CH3)2NH
CH3
O
Cl Cl
O
COOH
N(CH3)2
OH
-
BaseCH3
O
Cl Cl
O
COOH
CH2
Ethacrynic acid
 
Scheme 4: Synthesis of Ethacrynic acid 
 
 
(CH3)2NH.HCl + +
O
OH Mannich reaction
O CH2
OH
CH2
NCH3
CH3
O CH2
S
CH2
NCH3
CH3 CH2 NH
NH
CHNO2
CH3
Ranitidine
(HCHO)n
Furan-2-yl methanol
 
 Scheme 5: Synthesis of Ranitidine 
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Cl
CH3
O HCHO
N
H
NCl
CH2
O
CH2
N
Cl
CH CH2
N
Tripolidine
1-(4-chlorophenyl)ethanone
 
Scheme 6: Synthesis of Tripolidine 
 
 
CH3
O HCHO/HCl
N
H
O
N
+ H
Cl
-
OH
N
+ H
Cl
-
Trihexylphenidyl hydrochloride
Acetophenone
 
Scheme 7: Synthesis of Trihexylphenidyl hydrochloride 
 
Compounds which are synthesized by Mannich reaction: 
 
N
H
CH2 CH
NH2
OH
O
                    
NH
OH
O CH3
OH
 
Heteroauxin (Growth promoting hormone)  Oxyfedrine (Anti-anginal agent) 
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N
H
CH2
O
OH
                             
O
O
CH3
CH3
N
CH3
CH3
NH2
 
Tryptophan     Tutocaine (Local anesthetic) 
 
 
N
H
N
CH3
CH3
               
N CH3
O
CO
C6H5
OH  
Gramine      Atropine 
(Present in plants and plays defensive role)   
 
 
N CH3
CHOCOC6H5
COOCH3
    
N CH3 O
 
 Cocaine           Pseudopelletierine 
 
Fig 1: Compounds synthesized by Mannich reaction (Agarwal. O. P., 2008) 
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1.4. Mannich bases in Prodrug Design: 
Mannich bases have been also explored, into the area of prodrugs. The 
hydrochloride salt of mannich base of carbamazepine (anticonvulsant) with 
dipropylamine is found to be more than 104 fold soluble in water than the parent drug. 
Following intramuscular administration in rats, higher and more rapidly appearing 
carbamazepine plasma levels were observed from aqueous solutions of the N-mannich 
base prodrug than from administering a suspension of the parent drug. 
N
O NH N(C3H7)2 
Fig 2: Carbamazepine mannich base 
 Hetacillin, formed by condensation of ampicillin with acetone, is regarded as 
cyclic N-mannich base. Sodium ampicillin in solution loses almost 10% of its activity in 
1 h of room temperature at a concentration of 250 mg/ ml. Hetacillin, on the other hand, 
loses somewhat less than 10% activity in 6 h under identical conditions. The 
pharmacokinetics of oral and intravenous doses of ampicillin and hetacillin has been 
compared. Bioavailability studies showed 32% absorption from ampicillin capsules, 
while 42% absorption values from hetacillin capsules in non-fasting subjects. 
NNH
CH3 CH3
O
N
S
O
COOH
CH3
CH3
 
Fig 3: Hetacillin 
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 Rolitetracyclin, a prodrug of tetracyclines prepared by reacting pyrrolidine and 
formaldehyde is very soluble in water whereas the parent drug tetracycline has low 
solubility in water. 
CH3 OH
O
H
OH
H OH
N(CH3)2
OH
OH
CONH
N
 
Fig 4: Rolitetracycline 
 The concept of N-mannich base prodrug may be useful or improving the 
dissolution behavior of poorly soluble drugs in an effort of improves oral bioavailability 
of various NH – acidic compounds (chlozoxazone, phenytoin, sorbital, acetazolamide, 
chlorothiazide and allopurinol). In study, N-mannich bases with morpholine or piperidine 
were found to possess markedly greater (up to a factor of 2.000) intrinsic dissolution rates 
in comparison with the parent compounds. (Pandeya S.N. et al., 2003) 
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2. LITERATURE REVIEW 
 
2.1. Rita Bamnela et al., (2011) synthesized N-Mannich bases of 1-substituted methyl-
2-(substituted phenyl) benzimidazole derivatives were characterized by elemental 
analysis and spectral data (IR and 1H NMR). They have been evaluated for their 
antibacterial, anthelmintic and insecticidal activities against microbes, helminthes and 
insects. The below mentioned compounds (Fig–5) had exhibited significant 
anthelmintic activity while moderate to good antibacterial and insecticidal activities 
against helminthes, bacteria and insect selected as compared to standard drugs.  
N
N
CH2 R
1
R
  
 (Fig – 5) 
 
 
 
 
2.2. Mariappan G. et al., (2011) synthesized a novel series of 2-ethyl benzimidazole 
derivatives had been synthesized by the condensation of 2-ethyl benzimidazole with 
substituted primary and secondary amines. Their structures have been elucidated by 
UV-Vis, IR, 1H NMR and Mass spectral data. Among the synthesized derivatives     
1, 2, 8, 9 and 10 were found to have an effective anti-inflammatory response whereas 
compounds 2, 4, 6, 8 and 10 have potent analgesic response. There is no significant 
Code. No R R1 
4a 4-NO2 Piperazino 
4b 4-NO2 Diphenylamino 
4c 4-NO2 Morpholino 
4d 4-NO2 Diethanolamino 
4e 4-NO2 Imidazolo 
4f 4-NO2 Diethylamino 
4g 4-OH Piperazino 
4h 4-OH Diphenylamino 
4i 4-OH Morpholino 
4j 2-OH Piperazino 
4k 2-OH Diphenylamino 
4l 2-Cl Morpholino 
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difference in bioactivity of benzimidazoles derived from secondary and primary 
amines.  
N
N
CH2CH3
CH2 N
R2
R1
 
  (Fig – 6) 
 
 
 
2.3. Murugesan Sugumaran et al., (2011) synthesized a series of mannich bases of      
2-substituted benzimidazole were synthesized and characterized by their melting 
point and analytical thin layer chromatography. Structures of synthesized compounds 
were characterized by UV, IR, 1H NMR and Mass spectral analysis. The synthesized 
compounds were screened for antibacterial and anthelminitic activity. The result 
showed one of the compounds (Mannich base of 2-styryl benzimidazole) had more 
potent activity in both antibacterial and anthelminitic activity.  
N
N
CH2
N
C2H5
H5C2
CH=CH-C6H5
 
(Fig – 7) 
 
CODE -NR1R2 
1 Diethylamino 
2 Piperidino 
4 Diethanolamino 
6 3-chloroanilino 
8 3,4-dichloroanilino 
9 4-fluroanilino 
10 4-bromoanilino 
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2.4. Pankaj Srivastava et al., (2009) had synthesized mannich bases of                         
2-(benzimidazolyl aminomethyl) thiazolidin-4-one by amination at 5th position using 
formaldehyde and various secondary amines. The prepared compounds have been 
characterized by physico-chemical and spectral analysis and screened for their 
antibacterial activity. The below mentioned compounds (Fig – 8) were found to be 
remarkably effective compounds with respect to their inhibitory activity against gram 
positive bacteria Bacillus subtilis and gram negative bacteria, Pseudomonas 
aerugenosa and E.coli. 
N
N
CH2 N
N
H
S
O
R 
  (Fig – 8) 
 
 
2.5. Kalirajan R. et al., (2009) synthesized some new 2-substituted benzimidazoles 
like 2-(1H-benzo[d]imidazol-2-yl)benzoic acid (I) and 2-methyl benzimidazole (II) 
derivatives and they had characterized by TLC, elemental analysis, IR and 1H NMR 
spectroscopy. The synthesized compounds were screened for their anti-inflammatory, 
antibacterial and antifungal activities and all the compounds have highly significant 
activity when compared with standard drug. 
 
 
Code. No R 
C2 
N
CH3
H
 
C4 
 
ONH
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N
N
CH3
CH2 NH R
I II
CH2 NH R
N
N
HOOC
   (Fig – 9) 
 
2.6. Leonard J. T. et al., (2007) synthesized a new series of substituted benzimidazoles 
as 1-(substituted methyl)-2-(substituted phenyl) benzimidazole and characterized by 
1H NMR, IR and elemental analyses. The compounds were evaluated for anti-
inflammatory and antibacterial activity. The below mentioned compounds (Fig – 10) 
exhibited significant anti-inflammatory and antibacterial activities.  
N
N
CH2 NR
R1
    
 (Fig – 10) 
  
 
2.7. Leonard J. T. et al., (2006) synthesized a new series of substituted benzimidazoles 
as 1-(substituted methyl)-2-(substituted phenyl) benzimidazoles and characterized by 
IR, 1H NMR and elemental analysis. The compounds (Fig – 11) were evaluated for 
anti-inflammatory and antibacterial activity. In the anti-inflammatory study, the 
compounds (4, 5, 6 and 11) were produced good anti-inflammatory activity. In the 
Code NH – R 
I a & II a Morpholine 
I b & II b Piperidine 
I c & II c Diethyl amine 
I d & II d Diphenyl amine 
I e & II e Paracetamol 
I f & II f Acetanilide 
Code. 
No 
R1 NR 
1 3- NO2 Morpholine 
3 3- NO2 Piperazine 
4 3- NO2 Imidazole 
7 3- NO2 4-Methyl piperazine 
9 2- NH2 Piperazine 
10 2- NH2 Piperidine 
11 2- NH2 Diethyl amine 
12 2, 4-diCl Piperazine 
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antibacterial evaluation, the compounds (3, 6, 8 and 12) were produced good 
antibacterial activity. 
N
N
CH2 NR
R1
 
 (Fig – 11) 
 
 
2.8. Mohamed Al Messmary et al., (2010) synthesized a number of 2-substituted 
benzimidazoles were prepared by reaction of substituted benzoic acid with               
O-phenylenediamine, and then the products obtained were treated with secondary 
amines in the presence of formaldehyde in order to synthesized mannich bases. The 
synthesized products were characterized by physical and spectral analysis.  
N
N
CH2N
R
R
X
 
 (Fig – 12) 
 
2.9. Mohamed G Elerafi et al., (2010) synthesized a new series of substituted 
benzimidazoles of 1-(substituted methyl)-2-substituted phenyl benzimidazoles. The 
final products (Fig – 13) were characterized by IR, 1H NMR spectra and elemental 
analysis.  
 
Code. 
No 
NR R1 
3 4-Cl Piperazine 
4 4-Cl Imidazole 
5 4-Cl Diphenylamine 
6 4-Cl Dimethylamine 
8 4-Cl Diethylamine 
11 4-NH2 Diphenylamine 
12 4-NH2 4-methyl piperazine 
X Code R 
o-OH II a CH3 
p-OH II b CH3 
o-Cl II c CH2CH3 
p-Cl II d CH2CH3 
o-NO2 II e C6H5 
p-NO2 II f C6H5 
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N
N
CH2N
R
R
X
 
 (Fig – 13) 
 
2.10. Vijayaraghavan S. et al., (2009) synthesized a novel series of mannich bases by 
the reaction of 5-{2-(ethylthio)-1H–benzimidazole–1-yl}-methyl-1, 3, 4 – oxadiazole 
–2-thione with formaldehyde and appropriate amines. The final products were 
characterized by IR, 1H NMR spectra and elemental analysis. The antibacterial 
screening against S. aureus, E. coli and P. aeruginosa at three different 
concentrations revealed that compound containing 2-chloro-4-flurophenyl substituted 
derivative (Fig – 14) showed significantly active.  
N
N
S
CH2CH3
CH2
N N
O S
NH F
Cl
 
(Fig – 14) 
2.11. Periyasamy Selvam et al., (2010) synthesized a series of novel N-substituted 
benzimidazole derivatives and screened anti-viral activity against a HIV-1 and HIV-2 
in MT-4 cells and also cytotoxicity activity studied by MTT assay method. The novel 
compounds were synthesized through modifying the N-1 hydrogen of benzimidazole 
moiety with the substitution of sulphanilamide by mannich reaction. The final 
X Code R 
H II a CH3 
p-CH3 II b CH3 
p-CH3 II c CH2CH3 
o-OCH3 II d CH2CH3 
o-OCH3 II e Morpholine 
o-NH2 II f Piperidine 
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synthesized products were characterized by means of IR and PMR spectra. 
Benzimidazole derivative (Sulphadimidine) had inhibited the replication of HIV-1 
and 2 (EC50 = 35.40 µg/ ml and CC50>125 µg/ ml) in MT-4 cells.  
N
N
CH3
CH3
N
N
CH2 NH SO2NH
 
(Fig – 15) 
2.12. Anandarajagopal K. et al., (2010) synthesized a novel series of 2-mercapto 
benzimidazole derivatives by mannich reaction from 2-mercapto benzimidazole by 
reaction with compounds having secondary amine and formaldehyde. The purity of 
the synthesized compounds was checked by melting point and TLC and their 
structure was established by various analytical techniques such as IR and 1H NMR 
spectral studies. The final products were evaluated by anti-inflammatory, 
antimicrobial and anticonvulsant activities. The below mentioned compounds 1E, 1F 
and 1I were exhibited excellent anticonvulsant activity and also exhibited significant 
anti-inflammatory and antimicrobial activities. 
N
N
H
S
N
R
1
R
 
 (Fig – 16) 
 
Code N
R
1R
 
1E 
N
NH
 
1F 
N
O
 
1I N
O  
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2.13. Gigani Yaseen et al., (2010) synthesized some ‘best fit’ 2MBI derivatives 
(Mannich bases) and evaluated by in vitro antimicrobial assay using paper disc 
method. Dihydrofolate reductase (DHFR) is the important target for antimicrobial 
drugs belonging to the class of anti-metabolites as the enzyme plays an important role 
in the de novo purine synthesis. Since 2-mercapto benzimidazole (2MBI) shares 
structural similarity with purine nucleotides. The structures were reported the in silico 
screening to obtain best fit molecules as DHFR inhibitors. The structures of these 
molecules (Fig – 17) were elucidated by Infrared and they were subjected for in vitro 
antimicrobial activity against gram positive and gram negative bacteria. The 
compounds containing AMP and DHH were most potent activity observed when 
compared with ciprofloxacin as standard at concentration 200 µg/ ml. 
N
N
H
S
NH
R
 
 (Fig – 17) 
 
 
 
2.14. Philip Jesudason E. et al., (2009) synthesized a novel series of N-mannich bases 
of benzimidazole derivatives and characterized by 1H NMR, IR spectral studies and 
elemental analysis. The compounds were screened for analgesic and anti-
inflammatory activity. Corneal permeability and quantum chemical calculations were 
performed to correlate the hydrogen bonding ability with permeability and activity. 
The energies of the highest occupied molecular orbital (HOMO) and the lowest 
Code R= 
AMP 
N
N
NH
 
DHH 
NH NO2
O2N
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unoccupied molecular orbital (LUMO) were correlated with pharmacological activity. 
The semi-empirical PM3 calculations (quantum chemical calculations) revealed that 
ELUMO and energy gap ΔE were capable of accounting for the high in vitro bovine 
corneal permeability and activity of the compounds.  
 
N
N
R1
CH2 R2  
 (Fig – 18) 
 
 
 
2.15. Afaf H. El-masry et al., (2000) synthesized a new series of 3-(2-methyl 
benzimidazole-1-yl) propanoic acid hydrazide reacts with CS2/KOH give oxadiazole 
derivative from this mannich base were synthesized. The synthesized compounds 
were characterized by IR, 1H NMR and elemental analysis. The products (Fig – 19) 
were screened for antimicrobial activity.  
N
O
N
N
N
CH3
CH2 CH2
S
R
 
(Fig – 19) 
 
R1 R2 
H -N(CH3)2, -N(C2H5)2 
CH3 -N(C6H5)2 
-CH=CH-C6H5 -N(C2H5)2, 
NH
, 
ONH
 
R 
-N(C2H5)2 
ONH
 
NH N CH3
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2.16. Jubie S. et al., (2010) had synthesized a series of mannich bases of ciprofloxacin 
and norfloxacin with various benzimidazoles. The compounds were confirmed by 
physical parameters (solubility and melting point), TLC and at last spectroscopic 
methods (IR, NMR). The final compounds were screened for their antibacterial and 
antifungal activity by cup-plate method. All the benzimidazole substituted 
norfloxacin derivatives (NF1, NF2 and NF3) and ciprofloxacin derivatives (CF1, CF2 
and CF3) were exhibit significant activity against Candida albicans at 50, 100 µg/ ml. 
The benzimidazoles showed mild antibacterial activites and significant antifungal 
activities. 
N
COOHF
N
N
R
CH2
N
N
 
Mannich base (CF1 – CF3) 
N
COOHF
N
N
R
CH2
N
N
F
 
Mannich base (NF1 – NF3) 
R = H, CH2CH3, CH2CH2CH3  
(Fig – 20)
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3. AIM AND PLAN OF WORK 
 
3.1. Aim: 
 In the present century due to the advancement and changes in the culture and life 
style, new diseases are being existed among the human population that the search for 
better dugs still necessary. Synthesis, new more than ever, is a vital and interesting part of 
organic chemistry. Organic synthesis has, rightly commanded a good deal of attention 
from researchers who have to choose from different arrays of synthetic methods. 
Discovery of new drugs that is therapeutically useful and goes into clinics is a life time 
dream for medicinal chemist. Carbocyclic (or) heterocyclic ring systems comprise the 
core of chemical structures of the vast majority of therapeutic agents. The exploitation of 
a simple molecule with different functionalities for the synthesis of heterocyclic 
compounds is a worthwhile contribution in the chemistry of heterocycles. Heterocyles 
dominate medicinal chemistry – the majorities of drugs are heterocyclic or have 
heterocyclic structural compounds. (Anandarajagopal K., et al., 2010 and Ganiyat K. 
Oloyede., et al., 2011) 
 Benzimidazoles are remarkably effective compounds both with respect to their 
degree of virus inhibitory activity and favorable selectivity ratio. Several benzimidazole 
derivatives with N-1 substitution showed anti-viral activity against human cytomegalo 
virus and herpes simplex virus type-1. 2-substituted benzimidazole derivatives, one of the 
most important derivatives of benzimidazole are also known possess varies biological 
activities. The biological activities of these compounds depend upon the substitution on 
the benzimidazole at the N-1 (or) C-2 position. Since benzimidazole heterocyclic ring 
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system mimics the purine bases like adenine and guanine of nucleic acids, the N-1 
substituted benzimidazoles may be incorporated into the viral nucleic acids by enzymatic 
process and subsequently can alter the structure and function of nucleic acids resulting in 
the inhibition of viral growth (Periyasamy Selvam., et al., 2010). 
 Over the past few decades, Mannich bases of heterocyclic molecules have been 
grabbing the attention of the synthetic chemists for their wide gamut of biological 
activities ranging from antibacterial, anti cancer, anti parkinson to anti convulsant, anti 
inflammatory, analgesic and anti-HIV (Vijayaraghavan S., et al., 2009, Tewari R.K., et 
al., 1991, Dimmock J.R., et al., 1992 and Pandeya S.N., et al., 2003). The Mannich 
reaction is one of such. It involves the introduction of single carbon atom by the reaction 
of an active methylene compound with formaldehyde and a primary amine or secondary 
amine. Mannich reaction is a simple addition step without final elimination, this 
presumably reflects the fact that -+NH-R2 is a poorer leaving group than -+OH2. The 
products of many mannich reactions are referred to as Mannich bases and are themselves 
useful synthetic intermediates.  
Multi-component reactions constitute a major part in the present day organic 
synthesis with advantages ranging from lower reaction times, reproducibility and 
improve biologically active compounds. It has been observed that the presence of two 
(or) more heterocyclic moieties fused or linked enhance the biological profile of drug 
molecules by many folds. Mannich reaction has been employed in the synthesis of many 
useful chemical substances of medicinal and industrial interest.  
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In the present research, we decided to synthesize 2-substituted benzimidazole 
derivatives by conventional method. Further the study will extended to introduce 
sulphanilamide and piperazine group substitution on N-1 position of 2-substituted 
benzimidazole by Mannich reaction and to screen the newly synthesized compounds for 
their antibacterial and antifungal activity. 
3.2. Plan of the work: 
 To synthesize 2-substituted benzimidazole derivatives and their corresponding 
N- mannich bases. 
 To determine the physical properties such as percentage yield, melting point, 
Rf value, colour, solubility and nature of all the synthesized compounds     
(SR1 – SR9).  
 To determine and characterize the spectral data such as UV spectroscopy,    
FT-IR, 1H NMR and Mass spectra of all the synthesized compounds (SR1 – 
SR9). 
 To evaluate the biological activity such as antibacterial and antifungal activity 
of synthesized compounds (SR4 – SR9). 
 
 
 
 
  
 
EXPERIMENTAL 
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4. EXPERIMENTAL 
4.1. Materials and Instruments: 
 The melting points were recorded in open capillaries on Elico melting point 
apparatus and were uncorrected. Spectral analysis were performed in the Sophisticated 
Analytical Instrumentation Facility, Indian Institute of Technology, Chennai, using       
1H NMR (Bruker – NMR 500MHz) Spectrometer and Mass (JEOL GC mate) 
spectrometer, in Ideal Analytical and Research Institution, Puducherry, using FT-IR 
(Thermo Fischer – Nicolet iS5) and Adhiparasakthi College of Pharmacy  for  UV-
Visible Spectrometer (Double beam UV Spectrometer – SHIMADZU -1700). 
In 1H NMR, chemical shifts were reported in δ values using MeOD and     
DMSO-d6 are as a solvents and tetramethylsilane (TMS) as an internal standard with 
number of protons, multiplicities (s-singlet, d-doublet, t-triplet, q-quartet and m-
multiplet) in the solvent indicated. IR spectra were recorded as KBr pellets and intensities 
mentioned as s-strong, m-medium and w-weak. 
The reagents and solvents were commercially available (Rankem, SD fine, Loba 
and Fluka) and of synthetic grade. Glassware was oven or flame - dried for moisture 
sensitive reactions. When necessary, solvents and reagents were dried in prior to use. 
Solution or extracts in organic solvents were dried over anhydrous sodium sulphate or 
fused calcium chloride before evaporation to under vacuum using rotary evaporator. 
Analytical samples were dried in vacuum and they were free of significant impurities on 
TLC. For antimicrobial activity by using two gram positive bacteria (Staphylococcus 
aureus MTCC 740 and Bacillus subtilis MTCC 121) and two gram negative bacteria 
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(Escherichia coli MTCC 1302 and Pseudomonas aeruginosa MTCC 741) and two fungal 
organisms (Candida albicans ATCC 24433 and Trichophyton rubrum ATCC 2327) were 
collected from Microbial Resources Division, Kings Institute’s of Preventive Medicine, 
Guindy, Chennai. The nutrient agar medium and sabouraud’s dextrose agar medium were 
purchased from HI Laboratories Ltd., Mumbai, India. 
4.2. Methodology: 
Monitoring of Synthetic Reaction Procedures: 
Established synthetic procedures were employed for synthesis of compounds   
SR1 to SR9 and the reactions were monitored by Thin Layer Chromatography (TLC) 
employing 6’’ X 2’’ plates coated with 0.25 mm thick layer of silica gel (pre-activation 
by heating at 110° C for one h). Solvent systems of varying polarity ranging from 
methanol to water mixtures (9.5:0.5, 9:1, 8.5:1.5, 8:2 and 7:3) were used to monitor the 
reactions. The plates were visualized in an iodine chamber. 
Purification Techniques: 
Recrystallization: The crude products were recrystallized by charcoal treatment in 
appropriate solvent. Single solvent was used wherever possible and solvent mixtures 
were used if necessary.  
Authentication of Chemical Structures and Purity of Compounds: 
Chemical structure of products and their purity were ascertained by thin layer 
chromatography, UV-Visible spectrometer, melting point and various spectral techniques 
including Fourier Transform Infra Red Spectroscopy, Nuclear Magnetic Resonance 
Spectroscopy and Mass Spectroscopy. 
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4.3. Synthesis of compounds: 
4.3.1. Synthesis of 2–methyl-benzimidazole: (SR1)  
   13.5 g (0.125 mol) of O-phenylene diamine was placed in a 250 ml of round 
bottom flask and added 10.2 g (0.17 mol) of acetic acid. The mixture was heated on a 
water bath at 100° C for 6-8 h, cooled and added 10% sodium hydroxide solution slowly 
with constant rotation of the flask, until the mixture was just alkaline to litmus. The crude 
benzimidazole derivative was filtered at the pump, and then washed with ice cold water, 
drained well and washed again with 25 ml of cold water. The crude product was 
dissolved in 200 ml of boiling water; 2 g of decolorizing carbon was added and digested 
for 15 min. The product was filtered rapidly at the pump through preheated buchner 
funnel and flask. The filtrate was cooled to about 10° C and the filtered product of          
2-methyl-benzimidazole was again washed with 25 ml of cold water, dried at 100° C and 
weighed. (Vogel’s 2006, Ahuluwalia V.K. et al., 2000, Ansari K.F. et al., 2009) 
      
+ CH3COOH
N
N
H
CH3
O-phenylene diamine acetic acid
reflux for 6-8 h
2-methyl- benzimidazole
NH2
NH2
-2 H2O
 
Scheme 8: Synthesis of 2-methyl-benzimidazole 
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4.3.2. Synthesis of 2-ethyl-benzimidazole: (SR2)  
  13.5 g (0.125 mol) of O-phenylene diamine was placed in a 250 ml of round 
bottom flask and added 14.96 g (0.17 mol) of propionic acid. The mixture was heated on 
a water bath at 100° C for 6-8 h, cooled and added 10% sodium hydroxide solution 
slowly with constant rotation of the flask, until the mixture was just alkaline to litmus. 
The crude benzimidazole derivative was filtered at the pump, and then washed with ice 
cold water, drained well and washed again with 25 ml of cold water. The crude product 
was dissolved in 200 ml of boiling water; 2 g of decolorizing carbon was added and 
digested for 15 min. The product was filtered rapidly at the pump through preheated 
buchner funnel and flask. The filtrate was cooled to about 10° C and the filtered product 
of 2-ethyl-benzimidazole was again washed with 25 ml of cold water, dried at 100° C and 
weighed. 
 
NH2
NH2
+ CH3CH2COOH
N
N
H
CH2CH3
O-phenylene diamine propionic acid
reflux for 6-8 h
2-ethyl- benzimidazole
-2 H2O
 
Scheme 9: Synthesis of 2-ethyl-benzimidazole 
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4.3.3. Synthesis of 2-propyl-benzimidazole: (SR3)      
 13.5 g (0.125 mol) of O-phenylene diamine was placed in a 250 ml of round 
bottom flask and added 17.34 g (0.17 mol) of butyric acid. The mixture was heated on a 
water bath at 100° C for 6-8 h, cooled and added 10% sodium hydroxide solution slowly 
with constant rotation of the flask, until the mixture was just alkaline to litmus. The crude 
benzimidazole derivative was filtered at the pump, and then washed with ice cold water, 
drained well and washed again with 25 ml of cold water. The crude product was 
dissolved in 200 ml of boiling water; 2 g of decolorizing carbon was added and digested 
for 15 min. The product was filtered rapidly at the pump through preheated buchner 
funnel and flask. The filtrate was cooled to about 10° C and the filtered product of          
2-propyl-benzimidazole was again washed with 25 ml of cold water, dried at 100° C and 
weighed.  
 
 
NH2
NH2
+ CH3CH2CH2COOH
N
N
H
CH2CH2CH3
O-phenylene diamine butyric acid
reflux for 6-8 h
2-propyl- benzimidazole
-2 H2O
 
Scheme 10: Synthesis of 2-propyl-benzimidazole 
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4.3.4. Synthesis of 1-((sulphanilamido) methyl)-2-methyl-benzimidazole (SR4): 
 To the 15 ml of methanolic solution, 0.66 g (0.005 mol) of 2-methyl 
benzimidazole was added to 0.86 g (0.005 mol) of sulphanilamide slowly with constant 
stirring under rigorous ice cooling. The reaction mixture was cooled well and 0.138 ml 
(0.005 mol) of formaldehyde solution (37% v/v) was added slowly with constant stirring. 
The reaction mixture was then adjusted to the pH of 3.5 with hydrochloric acid. The 
reaction mixture was kept in efficient ice cooling for half an hour to avoid losses of 
formaldehyde and then refluxed on water bath up to 3 h. The reflux time was dependent 
upon the sulphonamide chosen. After refluxing, the refluxed mixture was cooled at 0° C 
for 4 days, when crystallized product was obtained, which was recrystallized with dry 
distilled ethanol and DMF. (Sheela Joshi et al., 2005) 
N
N
CH3
CH2 NH S
O
O
NH2
N
N
H
CH3 + HCHO + NH2 S
O
O
NH2
SulphanilamideFormaldehyde2-methyl benzimidazole
N-Mannich base of 2-methyl benzimidazole
-H2O
1 h stirring and reflux 
for another 3 h
 
Scheme 11: Synthesis of 1-((sulphanilamido) methyl)-2-methyl-benzimidazole 
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4.3.5. Synthesis of 1-((sulphanilamido) methyl)-2-ethyl-benzimidazole (SR5): 
 To the 15 ml of ethanolic solution, 0.73 g (0.005 mol) of 2-ethyl benzimidazole 
was added to 0.86 g (0.005 mol) of sulphanilamide slowly with constant stirring under 
rigorous ice cooling. The reaction mixture was cooled well and 0.138 ml (0.005 mol) of 
formaldehyde solution (37% v/v) was added slowly with constant stirring. The reaction 
mixture was then adjusted to the pH of 3.5 with hydrochloric acid. The reaction mixture 
was kept in efficient ice cooling for half an hour to avoid losses of formaldehyde and then 
refluxed on water bath up to 3 h. The reflux time was dependent upon the sulphonamide 
chosen. After refluxing, the refluxed mixture was cooled at 0° C for 4 days, when 
crystallized product was obtained, which was recrystallized with dry distilled ethanol and 
DMF. 
N
N
CH2CH3
CH2 NH S
O
O
NH2
N
N
H
CH2CH3 + HCHO + NH2 S
O
O
NH2
SulphanilamideFormaldehyde2-ethyl benzimidazole
N-Mannich base of 2-ethyl benzimidazole
-H2O
1 h stirring and reflux 
for another 3 h
 
Scheme 12: Synthesis of 1-((sulphanilamido) methyl)-2-ethyl-benzimidazole 
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4.3.6. Synthesis of 1-((sulphanilamido) methyl)-2-propyl-benzimidazole (SR6): 
 To the 15 ml of ethanolic solution, 0.80 g (0.005 mol) of 2-propyl benzimidazole 
was added to 0.86 g (0.005 mol) of sulphanilamide slowly with constant stirring under 
rigorous ice cooling. The reaction mixture was cooled well and 0.138 ml (0.005 mol) of 
formaldehyde solution (37% v/v) was added slowly with constant stirring. The reaction 
mixture was then adjusted to the pH of 3.5 with hydrochloric acid. The reaction mixture 
was kept in efficient ice cooling for half an hour to avoid losses of formaldehyde and then 
refluxed on water bath up to 3 h. The reflux time was dependent upon the sulphonamide 
chosen. After refluxing, the refluxed mixture was cooled at 0° C for 4 days, when 
crystallized product was obtained, which was recrystallized with dry distilled ethanol and 
DMF. 
N
N
CH2CH2CH3
CH2 NH S
O
O
NH2
N
N
H
CH2CH2CH3 + HCHO + NH2 S
O
O
NH2
SulphanilamideFormaldehyde2-propyl benzimidazole
N-Mannich base of 2-propyl benzimidazole
-H2O
1 h stirring and reflux 
for another 3 h
 
Scheme 13: Synthesis of 1-((sulphanilamido) methyl)-2-propyl-benzimidazole 
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4.3.7. Synthesis of 1-((pipearzino) methyl)-2-methyl-benzimidazole (SR7): 
To a solution 1.32 g (0.01 mol) of 2-methyl benzimidazole in 15 ml of ethanol, 
0.86 g (0.01 mol) of piperazine and 0.30 ml (0.01 mol) of formaldehyde solution        
(37% v/v) were added slowly with constant stirring under rigorous ice cold condition. 
The reaction mixture was kept in efficient ice cooling for half an hour to avoid losses of 
formaldehyde and then the reaction mixture was refluxed on water bath up to 30 min. The 
refluxed mixture was cooled at 0° C for 2-3 days in deep freeze. When crystallized 
product was obtained, filtered and dried. The product obtained was purified by 
recrystallized with dry distilled ethanol. (Rita Bamnela et al., 2011) 
 
N
N
H
CH3 + HCHO +
PiperazineFormaldehyde2-methyl benzimidazole
N-Mannich base of 2-methyl benzimidazole
-H2O
NH NH
N
N
CH3
CH2 N NH
1 h stirring and 
reflux for 30 min.
 
Scheme 14: Synthesis of 1-((piperazino) methyl)-2-methyl-benzimidazole 
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4.3.8. Synthesis of 1-((pipearzino) methyl)-2-ethyl-benzimidazole (SR8): 
To a solution 1.46 g (0.01 mol) of 2-ethyl benzimidazole in 15 ml of ethanol,   
0.86 g (0.01 mol) of piperazine and 0.30 ml (0.01 mol) of formaldehyde solution       
(37% v/v) were added slowly with constant stirring under rigorous ice cold condition. 
The reaction mixture was kept in efficient ice cooling for half an hour to avoid losses of 
formaldehyde and then the reaction mixture was refluxed on water bath up to 30 min. The 
refluxed mixture was cooled at 0° C for 2-3 days in deep freeze. When crystallized 
product was obtained, filtered and dried. The product obtained was purified by 
recrystallized with dry distilled ethanol. 
 
N
N
H
CH2CH3 + HCHO +
PiperazineFormaldehyde2-ethyl benzimidazole
N-Mannich base of 2-ethyl benzimidazole
-H2O
NH NH
N
N
CH2CH3
CH2 N NH
1 h stirring and 
reflux for 30 min.
 
Scheme 15: Synthesis of 1-((piperazino) methyl)-2-ethyl-benzimidazole 
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4.3.9. Synthesis of 1-((pipearzino) methyl)-2-propyl-benzimidazole (SR9): 
To a solution 1.60 g (0.01 mol) of 2-propyl benzimidazole in 15 ml of ethanol, 
0.86 g (0.01 mol) of piperazine and 0.30 ml (0.01 mol) of formaldehyde solution       
(37% v/v) were added slowly with constant stirring under rigorous ice cold condition. 
The reaction mixture was kept in efficient ice cooling for half an hour to avoid losses of 
formaldehyde and then the reaction mixture was refluxed on water bath up to 30 min. The 
refluxed mixture was cooled at 0° C for 2-3 days in deep freeze. When crystallized 
product was obtained, filtered and dried. The product obtained was purified by 
recrystallized with dry distilled ethanol. 
N
N
H
CH2CH2CH3 + HCHO +
PiperazineFormaldehyde2-propyl benzimidazole
N-Mannich base of 2-propyl benzimidazole
-H2O
NH NH
N
N
CH2CH2CH3
CH2 N NH
1 h stirring and 
reflux for 30 min.
 
Scheme 16: Synthesis of 1-((piperazino) methyl)-2-propyl-benzimidazole 
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5. BIOLOGICAL SCREENING 
5.1. Evaluation of in vitro antibacterial activity: 
 The in vitro anti bacterial study was carried out by using selected gastrointestinal 
tract infection (GIT) causing pathogens which includes two gram positive bacteria 
(Staphylococcus aureus MTCC 740 and Bacillus subtilis MTCC 121) and two gram 
negative bacteria (Escherichia coli MTCC 1302 and Pseudomonas aeruginosa MTCC 
741). The synthesized compounds (SR4 – SR9) were tested for anti bacterial activity by 
disc diffusion method (Collin C.H., et al., 1995). They were dissolved in DMSO and 
sterilized by filtering through 0.45 μm millipore filter. Final inoculum of 100 µl 
suspension containing 108 CFU/ ml of each bacterium was used. Nutrient agar medium 
was prepared and sterilized by an autoclave (121° C and 15 lbs for 20 min) and it 
transferred to previously sterilized petridishes (9 cm in diameter). After solidification, 
petriplates was inoculated with gram negative bacterial organisms Escherichia coli 
MTCC 1302, Pseudomonas aeruginosa MTCC 741 and gram positive bacterial 
organisms Staphylococcus aureus MTCC 740 and Bacillus subtilis MTCC 121 in sterile 
nutrient agar medium at 45° C under aseptic condition. Sterile Whatmann filter paper 
discs (previously sterilized in U.V. lamp) were impregnated with synthesized compounds 
at concentrations of 25, 100 µg/ disc were placed in the organism-impregnated petri 
plates under sterile condition. The plates were left for 30 min to allow the diffusion of 
compounds at room temperature. Antibiotic disc of ciprofloxacin (100 µg/ disc) was used 
as positive control, while DMSO used as negative control. Then the plates were 
incubated for 24 h at 37 ± 1° C. The zone of inhibition (Table-2) was calculated by 
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measuring the minimum dimension of the zone of no microbial growth around the each 
disc.  
5.2. Evaluation of in vitro anti fungal activity: 
 The synthesized compounds (SR4 - SR9) were tested for anti-fungal activity by 
disc diffusion method.  They were dissolved in DMSO and sterilized by filtering through 
0.45 μm millipore filter. Final inoculum of 100 µl suspension containing 108 CFU / ml of 
each fungus was used.  Sabouraud’s dextrose agar medium was prepared and sterilized by 
an autoclave (121° C and 15 lbs for 20 min) and transferred to previously sterilized 
petridishes (9 cm in diameter). After solidification, petriplates were inoculated with 
fungal organisms Candida albicans ATCC 24433 and Trichophyton rubrum ATCC 2327 
in sterile sabouraud’s dextrose agar medium at 45° C in aseptic condition. Sterile 
Whatmann filter paper discs (previously sterilized in U.V. lamp) were impregnated with 
synthesized compounds at a concentration of 25, 100 µg/ disc were placed in the 
organism-impregnated petri plates under sterile condition. The plates were left for 30 min 
to allow the diffusion of compounds at room temperature. Antibiotic disc of ketaconazole 
(100 µg/ disc) were used as positive control, while DMSO used as negative control. Then 
the plates were incubated for 48 h at 37±1° C for antifungal activity. The zone of 
inhibition (Table-3) was calculated by measuring the minimum dimension of the zone of 
no microbial growth around the each disc. 
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6. RESULTS AND DISCUSSION 
6.1. Synthetic Scheme: 
 The various strategies are available for the synthesis of benzimidazole and using a 
variety of starting material. In literature review, there are two general methods for the 
synthesis of 2-substituted benzimidazoles revealed that the condensation of                     
O-phenylenediamine with carboxylic acid derivatives like anhydrides, ester, amides and 
acid chlorides to yield the corresponding the titled benzimidazole compound which often 
requires strong acidic conditions, and sometimes combines with very high temperatures 
or microwave irradiation. The other way involves a two-step procedure that includes the 
oxidative cyclo-dehydrogenation of schiff bases, which are often generated from the 
condensation of phenylenediamines and aldehydes. (Mazaahir Kidwai., et al., 2010; 
Sharma S., et al., 2009; Tanious F.A., et al., 2004; Fairley T.A., et al., 1993; Czarny A., 
et al., 1996; Raut C.N., et al., 2009; Nagata K., et al., 2003; Chakrabarty M., et al., 2006; 
Bahrami K., et al., 2007; Aliyan H., et al., 2009). A microwave-assisted method for the 
synthesis of 2- substituted benzimidazoles in the presence of alumina-methanesulfonic 
acid (AMA) was also reported. In recent years, solvent – free synthesis of benzimidazoles 
under microwave irradiation using Yb(OTf)3, KSF clay, PPA, metal halide supported 
alumina and solid support have been reported. 
In step I, compounds in which the aliphatic ring was directly attached to the 
second position of the benzimidazole ring were substituted by our scheme. In this method 
2-substituted benzimidazoles were synthesized from O-phenylene diamine by reaction 
with mono aliphatic carboxylic acids. The reaction was neutralized with sodium 
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hydroxide solution and the crude benzimidazole derivatives (SR1-SR3) were isolated by 
filtration.  (Goel. P. K., et al., 2007). 
+ R - COOH
N
N
H
R
O-phenylene diamine carboxylic acid
reflux for 6-8 h
2-substituted benzimidazole
NH2
NH2
Step I:
Step II:
N
N
H
R
2-substituted benzimidazole
+ HCHO +
formaldehyde
1 h stirring and reflux for 
another 3 h / 30 min
- H2O
N
N
R
CH2 R
1
R1NH2 (or) R
1
2NH
primary (or) secondary amine
N-mannich base of 2-substituted benzimidazole
-2 H2O
 
 
 
 
 
 
 
 
 
Scheme 17: Synthetic route of title compounds 
Code. No R R1 
SR1 -CH3 - 
SR2 -CH2CH3 - 
SR3 -CH2CH2CH3 - 
SR4 -CH3 
SO2NH2NH
 
SR5 -CH2CH3 
SR6 -CH2CH2CH3 
SR7 -CH3 
NHN
 
SR8 -CH2CH3 
SR9 -CH2CH2CH3 
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 The reaction is carried out according to the reaction, the first step involve the 
synthesis of benzimidazole derivatives, in step II, these compounds were treated with the 
primary or secondary amines in the presence of formaldehyde to obtain the corresponding 
N-mannich bases. 
Mechanism of step I: 
N
NH2
H
H
+
O
R
OH NH2
N
H
OH
OH
R
- H2O
N
N
R
OH
H
H- H2O
N
N
H
R
 
Scheme 18: Reaction mechanism for synthesis of 2- substituted benzimidazole 
The Mannich reaction plays an essential role in the biosynthesis of important 
nitrogenous substances. In spite of the importance of the reaction, a satisfactory 
mechanism has not been elucidated. Several different mechanisms probably operate, 
depending upon pH and the nature of the active hydrogen of reactant (Eurckhalter J. H., 
et al., 1964).  
 This is the condensation between a compound containing at least one active 
hydrogen atom, formaldehyde and ammonia, a primary or a secondary amine (preferably 
as the hydrochloride). Compounds containing reactive hydrogen atom like ketones, acids 
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and their esters, phenols, furan, pyrrole, indole and their derivatives undergo this reaction 
very easily. The amine may be primary or secondary but the most convenient are 
secondary amines since they possess only one replaceable hydrogen atom (R2NH). The 
product with primary amine is secondary which further reacts to give tertiary amine and 
formaldehyde is the most common component in the mannich reaction (Agarwal O.P.,   
et al., 2008). 
Mechanism of step II: 
The first step in the mechanism is formation of an iminium ion from the amine 
(primary or secondary) and the formaldehyde:  
NH
R
R
O
H
H
+ N
+
R
R
H
H H
O
-
H
+
transfer N
R
R H H
OH
N
+
R
R
H
H
+ OH
-
in basic solution:
   
in acidic solution:
N
R
R H H
OH
N
R
R H H
OH2
+
N
+
R
R
H
H
+ H2O
 
In the next step, the carbonyl group forms an enolate (nucleophile) that attacks the 
iminium (electrophile):  
R
R O
R R
R O
-
R
N
+
R
R
H
H
N
R
R H
H R
R
O
R
 
Scheme 19: Mechanism of mannich reaction  
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The net result is that you have added an amino group in the beta position of a 
carbonyl compound. The reaction takes place usually under acidic conditions, which 
helps to generate the iminium intermediate (Abd El-Wareth A.O., et al., 2006). 
6.2. Interpretation of spectral data of synthesized compounds (SR1-SR9) 
6.2.1 Spectral analysis of 2-methyl benzimidazole (SR1): 
Spectroscopy Data: 
UV (MeOH): (Fig 22) 
 λmax   - 280.5 (εmax 0.2668) 
 λmax   - 243.0 (εmax 1.0140) 
IR (KBr): (Fig 23) 
Wave number (cm-1)   Assignment 
 3385 (s)   N-H stretching 
 3057 (w)   Aromatic (=C-H) stretching 
 2916 (m)   Aliphatic C-H stretching in CH2 
 1624 (s)   C=C stretching 
 1591 (s)   C=N stretching 
 736 (s)    Aromatic C-H out-of-plane bending 
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NMR (MeOD): (Fig 24) 
N
N
H
7.70
7.70
7.26
7.26
5.0
2.42
 
(4 aromatic protons, 3 aliphatic protons and one proton on nitrogen) 
          δ – Value    Assignment 
         7.70    (2H, m, Ar-H of C4 and C7) 
         7.26    (2H, m, Ar-H of C5 and C6) 
         5.0    (1H, s, broad, NH) 
         2.42    (3H, s, -CH3) 
MASS: (Fig 25) 
 The structure of the compound was further confirmed by its fragmentation peaks 
which are as follows: 
 
N
N
H
CH3 -e
-
m/z  132
N
N
H
+
CH3
m/z 132 (M+ peak)
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N
C
N
H
CH3
CH CH-
N
H
+
N
CH3
m/z  132 m/z  106(base peak)
.+
 
N
C
N
H
H -H
. N
N
H
CH2
+ - CH CH
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N. H
H
+
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  Fig 21: Fragmentation pattern of 2-methyl benzimidazole (SR1) 
 
Fig 22: UV spectrum of the compound SR1 
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Fig 23: IR spectrum of the compound SR1 
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Fig 24: 1H NMR spectrum of the compound SR1 
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Fig 25: Mass spectrum of the compound SR1 
46 
 
6.2.2 Spectral analysis of 2-ethyl benzimidazole (SR2): 
UV (MeOH): (Fig 27) 
 λmax   - 243.0 (εmax 0.4058) 
 λmax   - 274.0 (εmax 0.4591) 
IR (KBr): (Fig 28) 
Wave number (cm-1)   Assignment 
 3164 (s)   N-H stretching 
 3052 (w)   Aromatic (=C-H) stretching 
 2973 (m)    Aliphatic C-H stretching in –CH2 
 1622 (s)   C=C stretching 
 1589 (s)   C=N stretching 
 1324 (s)   CH3 bending 
 1457 (m)   CH2 bending 
 794 (s)    Aromatic C-H out-of-plane bending 
NMR (MeOD): (Fig 29) 
 
                (4 aromatic protons, 5 aliphatic protons and one proton on nitrogen) 
47 
 
 δ – Value   Assignment 
 7.70    (2H, m, Ar-H of C4 andC7) 
 7.26    (2H, m, Ar-H of C5 and C6)  
 5.0    (1H, s, broad, NH) 
 2.59    (2H, q, CH2, broad) 
 1.24    (3H, t, -CH3) 
MASS: (Fig 30) 
 The structure of the compound was further confirmed by its fragmentation peaks 
which are as follows: 
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CH3
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Fig 26: Fragmentation pattern of 2-ethyl benzimidazole (SR2) 
49 
 
 
Fig 27: UV spectrum of compound SR2 
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Fig 28: IR spectrum of compound SR2 
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Fig 29: 1H NMR spectrum of compound SR2 
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Fig 30: Mass spectrum of the compound SR2 
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6.2.3 Spectral analysis of 2-propyl benzimidazole (SR3): 
UV (MeOH): (Fig 32) 
 λmax   - 239.0 (εmax 0.5980) 
 λmax   - 296.5 (εmax 0.2899)  
IR (KBr): (Fig 33) 
Wave number (cm-1)   Assignment 
 3385 (s)   N-H stretching 
 3055 (w)   Aromatic (=C-H) stretching 
 2957 (m)   Aliphatic C-H stretching in –CH2 
 1632 (s)   C=C stretching 
 1591 (s)   C=N stretching 
 1320 (s)   CH3 bending 
 1457 (w)   CH2 bending 
 748 (s)    Aromatic C-H bending 
  NMR (MeOD): (Fig 34) 
 
(4 aromatic protons, 7 aliphatic protons and one proton on nitrogen) 
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 δ – Value   Assignment 
 7.70    (2H, m, Ar-H of C4 and C7) 
 7.26    (2H, m, Ar-H of C5 and C6)   
 5.0    (1H, s, broad, NH) 
 2.55    (2H, t, -CH2)       
 1.66    (2H, q, -CH2) 
 0.96    (3H, t, -CH3) 
Mass: (Fig 35)    
 The structure of the compound was further confirmed by its fragmentation peaks 
which are as follows:  
N
CH3N
H
-e
-
m/z  160
CH2CH2CH3
. N
N
H
+ CH CH-
N
H
N
+
m/z  117 m/z  91
N
N
H
+
CH3
m/z  160
(molecular ion peak)
N
N
H
+
CH3
m/z  160
(molecular ion peak)
 
 
55 
 
N
N
H
CH2CH2CH3
+.
CH3 N
N
H
CH2CH2
+
m/z  160 m/z  145
- CH CH
N
H
N
CH2CH2
+
m/z  119  
N
N
H H
+.
- CH2 CH2
N
N
H
CH3+.
m/z  160
m/z  132
CH
N
N
H
CH3
-
NH
N
CH3
.+
m/z  132
m/z 76
.+
 
N
C
N
H
H -H
. N
N
H
CH2
+ - CH CH
N
H
N
CH2
+
m/z  132 m/z  131 m/z  105
.+
N.
C
+
N
H
CH3 -CH4
N
C
+
N
.
- CH CH
N.
C
+
N
m/z  132 m/z  116
m/z  90
 
56 
 
N
N
H
CH2CH2CH3
+. C2H5
.-
N
N
H
CH2.
..
+
m/z  160 m/z  131
m/z  131
N
N
H
H
H
+
m/z  131
N
N. H
H
+
-HCNNH
C
+ H
m/z  104
N.
C
+
N
H
CH3 -CH3
N
C
+
N
H
.
N
H
C
+
N
CH CH-
m/z  132 m/z  117 m/z  91
N
C
N
H
CH3
CH CH-
N
H
+
N
CH3
m/z  132 m/z  106
.+
 
Fig 31: Fragmentation pattern of 2-propyl-benzimidazole (SR3) 
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Fig 32: UV spectrum of compound SR3 
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Fig 33: IR spectrum of compound SR3 
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Fig 34: 1H NMR spectrum of compound SR3 
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Fig 35: Mass spectrum of compound SR3 
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6.2.4 Spectral analysis of 1-((sulphonomido)-methyl)-2-methyl benzimidazole (SR4): 
Spectroscopy Data: 
UV (MeOH): (Fig 37) 
λmax   - 262.5 nm (εmax – 1.4568)   
IR (KBr): (Fig 38) 
Wave number (cm-1)   Assignment 
 3376 (s)   1° N-H stretching in sulphonamide 
 3263 (s)   2° N-H stretching in sulphonamide 
 3063 (w)   Aromatic (=C-H) stretching 
 2921 (m)   C-H stretching in –CH2  
 1595 (s)   C=N stretching 
 1460 (s)   C=C stretching 
 1438 (m)   CH3 asymmetric bending 
 1312 (s)   SO2 stretching 
 1386 (s)   C-N stretching (Aromatic tertiary amine) 
 746 (s)    C-H out-of-planes bending (Aromatic C-H) 
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NMR (DMSO-d6): (Fig 39) 
N
N
NH S
O
O
NH2
7.64
7.64
7.10
7.10
5.82
7.53
7.53
7.26
7.26
4.57
6.06
2.53
 
  (8 aromatic protons, 5 aliphatic protons and 3 protons on nitrogen) 
 δ – Value  Assignment 
 7.10 – 7.64  (8H, m, Ar-H – C4, C5, C6, C7 and 4-phenyl protons)  
 6.06   (2H, s, -CH2) 
 4.57   (2H, s, -SO2NH2) 
 5.82   (1H, s, -NH) 
 2.53   (3H, s, -CH3) 
Mass: (Fig 40) 
 The structure of the compound was confirmed by its fragmentation peaks which 
are as follows: 
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Fig 36: Fragmentation pattern of SR4 
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Fig 37: UV spectrum of the compound SR4 
 
 
 
 
 
 
 
 
 
66 
 
 
Fig 38: IR spectrum of the compound SR4 
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Fig 39: 1H NMR spectrum of the compound SR4 
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Fig 40: Mass spectrum of the compound SR4 
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6.2.5 Spectral analysis of 1-((sulphonomido)-methyl)-2-ethyl benzimidazole (SR5): 
UV (MeOH): (Fig 42) 
λmax    - 240.0 nm (εmax – 0.7504)   
λmax   - 293.0 nm (εmax – 0.3855) 
IR (KBr): (Fig 43) 
Wave number (cm-1)   Assignment 
 3378 (s)   1° N-H stretching in sulphonamide 
 3263 (s)   2° N-H stretching in sulphonamide 
 3057 (w)   Aromatic (=C-H) stretching 
 2938 (m)   C-H stretching in –CH2  
 1597 (s)   C=N stretching 
 1460 (s)   C=C stretching 
 1438 (m)   Aliphatic CH2 bending 
 1313 (s)   SO2 stretching 
 1387 (s)   C-N stretching (Aromatic tertiary amine) 
 744 (s)    C-H out-of-planes bending (Aromatic C-H) 
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NMR (DMSO-d6): (Fig 44) 
N
N
NH S
O
O
NH2
7.64
7.64
7.12
7.12
5.83
7.58
7.58
7.25
7.25
4.57
2.80
1.28
6.14
 
(8 aromatic protons, 7 aliphatic protons and 3 protons on nitrogen) 
 δ – Value  Assignment 
 7.12 – 7.64  (8H, m, Ar-H – C4, C5, C6, C7 and 4-phenyl protons)  
 6.14   (2H, s, -CH2) 
 5.83   (1H, s, -NH) 
 4.57   (2H, s, -SO2NH2) 
 2.80   (2H, q, -CH2) 
 1.28   (3H, t, -CH3) 
Mass: (Fig 45) 
The structure of the compound was confirmed by its fragmentation peaks which 
are as follows: 
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Fig 41: Fragmentation pattern of SR5 
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Fig 42: UV spectrum of the compound SR5 
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Fig 43: IR spectrum of the compound SR5 
75 
 
 
Fig 44: 1H NMR spectrum of the compound SR5 
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Fig 45: Mass spectrum of the compound SR5 
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6.2.6 Spectral analysis of 1-((sulphonomido)-methyl)-2-propyl benzimidazole (SR6): 
UV (MeOH): (Fig 47) 
λmax   - 263.0 nm (εmax – 0.7203)   
IR (KBr): (Fig 48) 
Wave number (cm-1)   Assignment 
 3385 (s)   1° N-H stretching in sulphonamide 
 3289 (s)   2° N-H stretching in sulphonamide 
 3026 (w)   Aromatic (=C-H) stretching 
 2931 (m)   C-H stretching in –CH2  
 1561 (s)   C=N stretching 
 1458 (s)   C=C stretching 
 1421 (m)   Aliphatic CH2 bending 
 1320 (s)   SO2 stretching 
 1383 (s)   C-N stretching (Aromatic tertiary amine) 
 748 (s)    C-H out-of-planes bending (Aromatic C-H) 
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NMR (DMSO-d6): (Fig 49) 
N
N
NH S
O
O
NH2
7.64
7.64
7.10
7.10
5.76
7.59
7.59
7.26
7.26
4.60
2.95
1.82
0.95
6.18
 
(8 aromatic protons, 9 aliphatic protons and 3 protons on nitrogen) 
 δ – Value   Assignment 
 7.10 – 7.64   (8H, m, Ar-H – C4, C5, C6, C7 and 4-phenyl protons)  
 6.18    (2H, s, -CH2) 
 5.76    (1H, s, -NH) 
 4.60    (2H, s, -SO2NH2) 
 2.95    (2H, t, -CH2) 
 1.78 – 1.85    (2H, m, -CH2) 
 0.95    (3H, t, -CH3) 
Mass: (Fig 50) 
 The structure of the compound was confirmed by its fragmentation peaks which 
are as follows: 
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Fig 46: Fragmentation pattern of SR6 
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Fig 47: UV spectrum of the compound SR6 
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Fig 48: IR spectrum of the compound SR6 
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Fig 49: 1H NMR spectrum of the compound SR6 
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Fig 50: Mass spectrum of the compound SR6 
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6.2.7 Spectral analysis of 1-((piperazino)-methyl)-2-methyl benzimidazole (SR7): 
UV (MeOH): (Fig 52) 
λmax   - 280.0 nm (εmax – 0.3619)   
λmax   - 273.5 nm (εmax – 0.2915) 
λmax    - 237.5 nm (εmax – 0.3762)   
IR (KBr): (Fig 53) 
Wave number (cm-1)   Assignment 
 3409 (w)   2° N-H stretching in piperazine 
 3063 (w)   Aromatic (=C-H) stretching 
 2933 (m)   C-H stretching in CH2 group 
 2874 (m)   C-H stretching in piperazine 
 1622 (s)   C=N stretching 
 1450 (s)   C=C stretching 
 1415 (s)   CH2 asymmetric bending 
 1346 (s)   C-N stretching (Aromatic tertiary amine) 
 736 (s)    C-H out-of-plane bending (Aromatic C-H) 
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NMR (DMSO-d6): (Fig 54) 
 
(4 aromatic protons, 13 aliphatic protons and 1 proton on nitrogen) 
 δ – Value   Assignment 
 7.15 – 7.64   (4H, m, Ar-H – C4, C5, C6 and C7)  
 5.47     (2H, s, -CH2) 
 2.53    (3H, s, -CH3) 
 2.37 – 2.93   (8H, m, CH2 of piperazine) 
 1.13    (1H, s, -NH) 
Mass: (Fig 55) 
The structure of the compound was confirmed by its fragmentation peaks which 
are as follows: 
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Fig 51: Fragmentation pattern of SR7 
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Fig 52: UV spectrum of the compound SR7 
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Fig 53: IR spectrum of the compound SR7 
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Fig 54: 1H NMR spectrum of the compound SR7 
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Fig 55: Mass spectrum of the compound SR7 
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6.2.8 Spectral analysis of 1-((piperazino)-methyl)-2-ethyl benzimidazole (SR8): 
UV (MeOH): (Fig 57) 
λmax   - 280.5 nm (εmax – 0.2572)   
λmax   - 274.5 nm (εmax – 0.2415) 
λmax   - 242.5 nm (εmax – 0.2018)   
IR (KBr): (Fig 58) 
Wave number (cm-1)   Assignment 
 3416 (w)   2° N-H stretching in piperazine 
 3053 (w)   Aromatic (=C-H) stretching 
 2936 (m)   C-H stretching in CH2 group 
 2796 (m)   C-H stretching in piperazine 
 1622 (s)   C=N stretching 
 1429 (s)   CH2 asymmetric bending 
 1347 (s)   C-N stretching (Aromatic tertiary amine) 
 741 (s)    C-H out-of-plane bending (Aromatic C-H) 
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NMR (DMSO-d6): (Fig 59) 
N
N
N NH
7.64
7.64
7.15
7.15
2.37
2.37 2.93
2.93
1.13
2.59
1.28
5.61
 
(4 aromatic protons, 15 aliphatic protons and 1 proton on nitrogen) 
 δ – Value   Assignment 
 7.15 – 7.64   (4H, m, Ar-H – C4, C5, C6, C7)  
 5.61    (2H, s, -CH2) 
 2.37 - 2.93   (10H, m, CH2 of piperazine and CH2 of ethyl group) 
 1.28    (3H, t, -CH3) 
 1.13    (1H, s, -NH) 
Mass: (Fig 60) 
The structure of the compound was confirmed by its fragmentation peaks which 
are as follows: 
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Fig 56: Fragmentation pattern of SR8 
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Fig 57: UV spectrum of the compound SR8 
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Fig 58: IR spectrum of the compound SR8 
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Fig 59: 1H NMR spectrum of the compound SR8 
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Fig 60: Mass spectrum of the compound SR8 
99 
 
6.2.9 Spectral analysis of 1-((piperazino)-methyl)-2-propyl benzimidazole (SR9): 
UV (MeOH): (Fig 62) 
λmax   - 280.5 nm (εmax – 0.2052) 
λmax    - 274.0 nm (εmax – 0.1995) 
λmax   - 233.5 nm (εmax – 0.4237) 
IR (KBr): (Fig 63) 
Wave number (cm-1)   Assignment 
 3385 (w)   2° N-H stretching in piperazine 
 3026 (w)   Aromatic (=C-H) stretching 
 2934 (m)   C-H stretching in CH2 group 
 2874 (m)   C-H stretching in piperazine 
 1631 (s)   C=N stretching 
 1430 (m)   CH2 asymmetric bending 
 1347 (s)   C-N stretching (Aromatic tertiary amine) 
 749 (s)    C-H out-of-plane bending (Aromatic C-H) 
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NMR (DMSO-d6): (Fig 64) 
 
(4 aromatic protons, 17 aliphatic protons and 1 proton on nitrogen) 
 δ – Value   Assignment 
 7.15 – 7.64   (4H, m, Ar-H – C4, C5, C6 and C7)  
 5.47     (2H, s, -CH2) 
 2.64 – 2.93   (8H, m, CH2 of piperazine) 
 2.36    (2H, t, -CH2) 
 1.81 – 1.84   (2H, m, -CH2) 
 1.15    (1H, s, -NH) 
 0.94    (3H, t, -CH3) 
Mass: (Fig 65) 
 The structure of the compound was confirmed by its fragmentation peaks which 
are as follows: 
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Fig 61: Fragmentation pattern of SR9 
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Fig 62: UV spectrum of the compound SR9 
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Fig 63: IR spectrum of the compound SR9 
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Fig 64: 1H NMR spectrum of the compound SR9 
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Fig 65: Mass spectrum of the compound SR9 
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6.3. Table - 1:  Physical and Analytical data of the synthesized compounds 
 
Code    
No. Name Nature Solubility 
Molecular 
weight (g) 
Molecular 
formula 
Melting 
point (° C) 
Percentage 
yield 
(% w/w) 
Rf  values 
(CH3OH:  
H2O) 8:2 
 
SR1 
 
2-methyl-1-H-
benzimidazole 
Light yellow 
crystalline, 
solid 
Freely soluble: Methanol. 
Soluble: Ethanol, benzene, 
acetone and chloroform. 
Insoluble: Water, hexane and 
ethyl acetate. 
132.16 C8H8N2 
176 
* (174-178) 
60.73 0.92 
 
SR2 
 
2-ethyl-1-H- 
Benzimidazole 
Yellowish 
white crystals 
Freely soluble: Methanol and 
acetone. 
Soluble: Benzene, ethanol, 
ethyl acetate and chloroform. 
Insoluble: Hexane and water. 
146.18 C9H10N2 
211 
* (213-215) 
38.89 0.72 
SR3 
2-propyl-1-H-
benzimidazole 
Light yellow 
crystals 
Freely soluble: Methanol. 
Soluble: Benzene, ethanol, 
ethyl acetate, chloroform and 
acetone. 
Insoluble: Hexane and water. 
160.21 C10H12N2 
183 
* (180-184) 
85.86 0.78 
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SR4 
1-
((sulphanilamido
) methyl)-2-
methyl-
benzimidazole 
Blackish red 
crystals 
Soluble: Methanol.  
Slightly soluble: Acetone, 
benzene, ethanol, ethyl 
acetate and chloroform. 
Insoluble: Hexane and water. 
316.37 C15H16N4O2S 142  45.58 0.93 
SR5 
1-
((sulphanilamido
) methyl)-2-
ethyl-
benzimidazole 
Light 
yellowish 
white powder 
Soluble: Acetone. 
Slightly soluble: Methanol, 
ethyl acetate and chloroform. 
Insoluble: Ethanol, benzene, 
hexane and water. 
330.40 C16H18N4O2S 123 31.61 0.81 
SR6 
1-
((sulphanilamido
) methyl)-2-
propyl-
benzimidazole 
Black crystals 
Soluble: Methanol, ethanol 
and acetone. 
Slightly soluble: Benzene, 
ethyl acetate and chloroform. 
Insoluble: Hexane and water. 
344.43 C17H20N4O2S 149 28.45 0.82 
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SR7 
1-((piperazino) 
methyl)-2-
methyl-
benzimidazole 
Light brown 
crystals 
Soluble: Methanol. 
Slightly soluble: Ethanol, 
hexane, acetone, ethyl acetate 
and chloroform. 
Insoluble: Benzene and 
water. 
230.30 C13H18N4 148 71.17 0.86 
SR8 
1-((piperazino) 
methyl)-2-ethyl 
–benzimidazole 
Brownish 
crystals 
Soluble: Methanol and 
ethanol. 
Slightly soluble: Chloroform, 
ethyl acetate, acetone and 
hexane. 
Insoluble: Benzene and 
water. 
244.33 C14H20N4 161 92.70 0.84 
SR9 
1-((piperazino) 
methyl)-2-
propyl-
benzimidazole 
Brownish 
crystals 
Soluble: Methanol, ethanol 
and chloroform. 
Slightly soluble: Acetone, 
ethyl acetate and benzene. 
Insoluble: Hexane and water. 
258.36 C15H22N4 174 69.10 0.87 
 
 * Reported melting points. (Jubie S., et al., 2010; Kalirajan R., et al., 2009) 
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6. 4. A. Screening of antibacterial activity: 
 The synthesized compounds were evaluated in vitro anti bacterial activity against 
gram negative bacteria Escherichia coli MTCC 1302, Pseudomonas aeruginosa MTCC 
741 and gram positive bacteria Staphylococcus aureus MTCC 740 and Bacillus subtilis 
MTCC 121. These are the agents commonly causes gastrointestinal tract infection and 
biliary tract infection. The gram negative organism Escherichia coli and Pseudomonas 
aeruginosa causes septicemia, gastroenteritis with mild to severe bloody diarrhea, 
hemorrhagic colitis and hemolytic-uremic syndrome. The gram positive organism 
Staphylococcus aureus and Bacillus subtilis causes diarrhoea, pyogenic infection and 
septicemia.  
 As per the data obtained, it was confirmed that all the tested compounds possess 
antibacterial activity against both gram positive and gram negative organisms.  
 The compound SR4 showed the significant activity in the following order: 
Staphylococcus aureus > Pseudomonas aeruginosa > Bacillus subtilis > Escherichia coli. 
 The compound SR5 showed the significant activity in the following order: 
Staphylococcus aureus > Pseudomonas aeruginosa > Escherichia coli > Bacillus subtilis. 
 The compound SR6 showed the significant activity in the following order: 
Bacillus subtilis > Pseudomonas aeruginosa > Escherichia coli > Staphylococcus 
aureus.  
 The compound SR7 showed the significant activity in the following order: 
Escherichia coli > Pseudomonas aeruginosa > Bacillus subtilis > Staphylococcus aureus. 
 The compound SR8 showed the significant activity in the following order: 
Escherichia coli > Pseudomonas aeruginosa > Bacillus subtilis > Staphylococcus aureus. 
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 The compound SR9 showed the significant activity in the following order: 
Escherichia coli ≥ Pseudomonas aeruginosa > Bacillus subtilis > Staphylococcus aureus.  
However the antibacterial activity of all the tested compounds against the tested 
organisms was found to be less than that of standard antibacterial drug ciprofloxacin at 
tested dose level.  
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Table 2: In vitro antibacterial activity of synthesized compounds by disc diffusion method 
Microorganisms 
 
Diameter of  zone of inhibition (in mm) 
SR4 
(μg/ disc) 
SR5 
(μg/ disc) 
SR6 
(μg/ disc) 
SR7 
(μg/ disc) 
SR8 
(μg/ disc) 
SR9 
(μg/ disc) 
 
Ciprofloxacin 
(μg/disc) 
25 100 25 100 25 100 25 100 25 100 25 100 
 
100 
Staphylococcus 
aureus 
17 21 17 25 12 17.3 12 15 11 15.6 10 16 
 
28 
Bacillus subtilis 13 17 11 14 21 27 11 16.4 12.6 17.5 13 16 
 
29 
Escherichia coli 12 17 13 17 19 22.3 20 25 21 27 14 17 
 
30 
Pseudomonas 
aeruginosa 
15 18 17 22 20 24 17 21.5 21 26 14 17 
 
32 
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6. 4. B. Screening of antifungal activity: 
The synthesized compounds were evaluated for in vitro antifungal activity against 
two fungal organisms Candida albicans ATCC 24433 and Trichophyton rubrum ATCC 
2327. These organisms cause serious dental infections. As per the data obtained, it was 
confirmed that all the tested compounds possessed anti-fungal activity. However, SR9,    
1-((piperazino) methyl)-2-propyl-benzimidazole exhibited more potent anti fungal 
activity against both fungal organisms among the test compounds.  
The compound SR4 showed the significant activity in the following order: 
Candida albicans > Trichophyton rubrum. The compound SR5 showed the significant 
activity in the following order: Candida albicans > Trichophyton rubrum. The compound 
SR6 showed the significant activity in the following order: Trichophyton rubrum > 
Candida albicans. The compound SR7 showed the significant activity in the following 
order: Trichophyton rubrum > Candida albicans. The compound SR8 showed the 
significant activity in the following order: Candida albicans > Trichophyton rubrum. The 
compound SR9 showed the significant activity in the following order: Trichophyton 
rubrum > Candida albicans.  
However, the anti-fungal activity of the compound SR9 against the tested 
organism was found to be less than that of antifungal drug ketoconazole at tested dose 
level.  
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Table 3: In vitro antifungal activity of synthesized compounds by disc diffusion method 
Microorganisms 
 
Diameter of  zone of inhibition (in mm) 
SR4 
(μg/ disc) 
SR5 
(μg/ disc) 
SR6 
(μg/ disc) 
SR7 
(μg/ disc) 
SR8 
(μg/ disc) 
SR9 
(μg/ disc) 
 
Ketoconazole 
(μg/ disc) 
25 100 25 100 25 100 25 100 25 100 25 100 
 
100 
Candida albicans  16 21 17 21 14 17 11 14 20 22 23 26 31 
Trichophyton rubrum 12 15 14 17.5 16 19.1 13 18 17 20 24 29 30 
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Fig 66: Antibacterial activity of tested compounds against tested microorganisms  
Staphylococcus aureus and Bacillus subtilis 
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Fig 67: Antibacterial activity of tested compounds against tested microorganisms  
Escherichia coli and Pseudomonas aeruginosa 
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Fig 68: Antifungal activity of tested compounds against tested microorganisms  
Candida albicans and Trichophyton rubrum 
 
  
 
SUMMARY AND 
CONCLUSION  
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7. SUMMARY AND CONCLUSION 
 
 The current interest in the development of new antimicrobial chemotherapy 
has been the mainstay of medicinal intervention against infectious diseases caused by 
various pathogens. A matter of concern in the treatment of microbial infections is the 
limited number of efficacious antimicrobial drugs. There is a real perceived need for 
the discovery of new compounds that are endowed with antimicrobial activities, 
possibly acting through mechanism of action, to which many clinically relevant 
pathogens are now resistant (Uday Kalidhar., 2011). In order to expand the group of 
benzimidazole derivatives, we synthesized several new benzimidazole ring containing 
N-mannich bases. It has been observed that the presence of two (or) more heterocyclic 
moieties fused or linked enhance the biological profile of drug molecules by many 
folds.  
 The appropriate carboxylic acids were reacted with O-phenylene diamine to 
give the corresponding 2-substituted benzimidazole in good to excellent yields by 
Phillip’s reaction. Then, a series of six novel mannich bases of 2-alkyl substituted 
benzimidazole derivatives were synthesized using mannich reaction by reaction with 
amines (primary and secondary) and formaldehyde. The purity of the synthesized 
compounds was checked by performing Thin Layer Chromatography (TLC) and 
determining melting points. 
 We reported our results from a study of replacing the N-1 hydrogen of novel 
benzimidazole derivatives with different types of substitutions like sulphanilamide 
and piperazine to form N-methyl substituted benzimidazole derivatives by mannich 
reaction. The structure of the synthesized compounds were elucidated by physical and 
spectral (UV, IR, 1H NMR and Mass) analysis. The NH band (3164-3385 cm-1) and 
NH proton signal (δ 4.80 – 5.0 ppm) of 2-substituted benzimidazole in IR and          
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1H NMR spectrum respectively in the synthesized compounds (SR1–SR3), confirmed 
the formation of benzimidazole nucleus. In SR1, 1H NMR spectrum showed a singlet 
for 3 protons at δ 2.42 confirmed the substitution of methyl group at C2 of 
benzimidazole nucleus. In SR2, gave quartet peak for 2 protons at δ 2.59 and a triplet 
peak for 3 protons at δ 1.27 indicated the presence of ethyl group at C2 of 
benzimidazole. In SR3, a two triplet peak for 5 protons at δ 2.55 and δ 0.96 and a 
multiplet peak for 2 protons at δ 1.66 indicated the presence of propyl group at C2 of 
benzimidazole. 
The IR spectrum of each N-mannich bases of SR4 to SR6 showed the 
characteristic IR absorption bands in the region of 3376-3385 cm-1, 3263-3289 cm-1 
and 1312-1320 cm-1 due to the presence of primary amino, secondary amino and SO2 
stretching of sulphonamide moiety. The structural confirmation of each N-mannich 
bases of SR4 to SR6 was further made using 1H NMR spectra. It showed signals at     
δ, ppm: 6.06 - 6.18 (2H, s, -CH2 proton), 4.57 – 4.60 (2H, s, SO2NH2 proton) and 5.76 
– 5.83 (1H, s, NH of sulphonamide). Thus, confirmed the proposed structures for 
above N-mannich bases of corresponding 2-substituted benzimidazole derivatives.  
The IR spectrum of each N-mannich bases of SR7 to SR9 showed the 
characteristic IR absorption bands in the region of 3385 - 3416 cm-1 due to the 
presence of 2° N-H (secondary amino) streching of piperazine ring. The structural 
confirmation of each N-mannich bases of SR7 to SR9 was further made using 1H NMR 
spectra. It showed signals at δ, ppm: 2.37 – 2.93 (8H, m, -CH2 of piperazine), 5.47 – 
5.61 (2H, s, CH2 proton) and 1.13 – 1.15 (1H, s, NH of piperazine). Thus, confirmed 
the proposed structures for above N-mannich bases of corresponding 2-substituted 
benzimidazole derivatives. 
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The structural confirmation of synthesized compounds of SR1 to SR9 was 
further made using Mass spectra. The molecular ion (M+) peaks such as 132.12, 
146.21, 160.11, 316.37, 330.40, 344.43, 230.30, 244.33 and 258.36 for SR1, SR2, SR3, 
SR4, SR5, SR6, SR7, SR8 and SR9 respectively corresponded with their molecular 
weights. The predicted chemical structure of title compounds was further supported 
by the fragmentation peaks. 
The compounds were screened for their antibacterial and antifungal activities. 
The activities reported by means of zone of inhibition in millimeter. All the 
compounds showed very good antibacterial and antifungal activities at the tested 
dose level.  
The sulphanilamide group containing N-mannich bases were more superior for 
inhibiting the growth of Staphylococcus aureus and Bacillus subtilis than piperazine 
containing N-mannich bases. Among the compounds, SR4 to SR6, the compound SR5 
was more active than the other compounds against the growth of Staphylococcus 
aureus. Likewise, the compound SR6 was more active than SR4 and SR5 to inhibit 
the growth of Bacillus subtilis. 
The piperazine group containing N-mannich bases were more superior for 
inhibiting the growth of Escherichia coli and Pseudomonas aeruginosa than 
sulphanilamide group containing N-mannich bases. Among the compounds SR7 to 
SR9, the compound SR8 was more active than the other compounds against the growth 
of Escherichia coli and Pseudomonas aeruginosa. 
Among the tested compounds, piperazine derivatives were more superior to 
sulphanilamide derivatives against gram negative bacteria. But sulphanilamide 
derivatives were more active than piperazine derivatives against gram positive 
bacteria. 
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The anti-fungal evaluation of compounds (SR4 to SR9), the piperazine group 
containing N-mannich bases were more superior for inhibiting the growth of Candida 
albicans and Trichophyton rubrum than sulphanilamide group containing N-mannich 
bases. Among the compounds of SR7 to SR9, the compound SR9 was more active than 
the other compounds against the growth of Candida albicans and Trichophyton 
rubrum. 
Even though, the anti microbial activity of tested compounds was less than 
their standard compounds are ciprofloxacin (antibacterial) and ketoconazole 
(antifungal) in the present study. In future study, it could be increased (or) equalized 
by altering the number of carbon atoms in side chain (or) introducing aromatic ring 
(or) substituted aromatic ring (or) heterocyclic ring (or) by introducing double bond in 
side chain in the 2nd position of benzimidazole nucleus. In other way, the synthesis of 
2-substituted benzimidazoles can be altering the complex with amines, like as 
pyrrolidine, imidazole, piperidine, morpholine and N-methyl piperazine etc. in the    
1st position of benzimidazole nucleus. 
Since a fewer species have been used in this study, it was warranted to screen 
these compounds with varied species and resistant strains. Further experiments were 
needed to elucidate their exact mechanism of activity. These results suggest that the 
benzimidazole ring is an important pharmacophore in modern drug discovery and the 
tested derivatives of benzimidazoles have excellent scope for further development as 
commercial antimicrobial agents in the chemotherapeutic approach in human. Our 
findings will prove useful to those chemists, pharmacists, medicinal chemists who are 
interested in the synthesis of potential Mannich bases as drugs with minimum side 
effects and also have comparatively low cost.  
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